Determination of Optimal Cell and Plasmid Concentration for
Transfection of I-SceI by DR-GFP Reporter
Madison Ambrose, Xueqian Cheng, Lulu Wang, Guang Peng
The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Prevention

Results

Introduction

Negative Control

DNA damage is a common cause of cancer. One way it is caused is by
interstrand crosslinks (ICLs); interstrand crosslinks are a result of two
separate strands of DNA becoming connected by a covalent bond [1].
These ICLs are cytotoxic, causing several metabolic processes and DNA
replication to be halted [2]. One of the cells main repair mechanisms for
interstrand cross-links is homologous recombination (HR) [2].
While HR is preferred in healthy cells to eliminate ICLs, ICLs are
commonly used as an avenue of chemotherapy in attempts to create
more DNA damage, therefore promoting natural apoptosis. As a result, a
cancer treatment that is currently being explored is a HR inhibitor drug.
The HR inhibitor drug will be used to inhibit the HR mechanisms,
therefore keeping the ICLs and allowing for quicker apoptosis of cancer
cells. In the following study, direct repeat green fluorescent protein (DRGFP) was transfected with the I-SceI plasmid to measure HR in cells.
Specifically, the most effective cell and plasmid concentration was
determined to achieve the highest transfection rate.
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Figure 2:
The following plots indicate the transfection rate of the
1ug of I-SceI plasmid in various cell concentrations
against both a positive and negative control. The
various concentrations that were tested include
(bottom, left to right), 1*10^5, 3*10^5 5*10^5, and
9*10^5 cells/mL. The most effective cell concentration
was 1x10*5 with a transfection rate of 14.0 per 1000
cells.
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Materials and Methods
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• The I-SceI plasmid was extracted
using the standard protocol.

Cell
Concentration

• The cells of concentrations 1*105,
3*105, 5*105, and 9*105 cells/mL
were transfected with the I-SceI
plasmid using the standard protocol.
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Figure 3:
The following plots indicate the transfection rate of the
of I-SceI plasmid in various concentrations at 1x10^5
cells/mL against both a positive and negative control.
The various plasmid concentrations that were
0.5ug,1ug,1.5ug,2ug. The most effective cell
concentration was 1.5ug with a transfection rate of
16.1 cells per 1000 cells.
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• Once the ideal cell concentration
was determined, the procedure
was repeated with I-SceI plasmid
amounts of 0.5ug,1.5ug, 1ug, &
2ug.
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The left plot displays the results of the flow cytometry assay for the negative control, displaying a
transfection rate of 0.41 per 1000 cells. The middle plot demonstrates the transfection rate of 2.01 per
1000 cells for the plasmid of interest, I-SceI. The furthest right plasmid, GFP, served as the positive
control and gave a transfection rate of 65.9 per 1000 cells. The results of this test indicated that I-SceI is
capable of transfection, however, the transfection rate will be much lower than the GFP positive control.
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The following images illustrate the success of the transfection in the cell. The negative control indicates that
there are no transfected cells due to absence of a green fluorescent color. The positive control indicates
that there was a successful transection. The plate with 1.0ug of plasmid in 1*10^5 cells/mL and 2.0ug of
plasmid in 1*10^5 cells/mL indicates a successful transfection similar to the rate of transfection displayed in
Figures 2 and 3.
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The determined cell concentration, plasmid concentration, and produced transfection rate can
be used in the future to test the effectiveness of an HR inhibit drug by determining how much
the transfection rate was reduced. Additionally, further studies can be done to determine the
correct concentration and ideal time of drug introduction to ensure optimal HR inhibition.

